help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tornovsky, S.
Right arrow Articles by Glaser, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tornovsky, S.
Right arrow Articles by Glaser, B.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 12 6224-6234
Copyright © 2004 by The Endocrine Society

Hyperinsulinism of Infancy: Novel ABCC8 and KCNJ11 Mutations and Evidence for Additional Locus Heterogeneity

Sharona Tornovsky, Ana Crane, Karen E. Cosgrove, Khalid Hussain, Judith Lavie, Ma’ayan Heyman, Yaron Nesher, Na’ama Kuchinski, Etti Ben-Shushan, Olga Shatz, Efrat Nahari, Tamara Potikha, David Zangen, Yardena Tenenbaum-Rakover, Liat de Vries, Jesús Argente, Ricardo Gracia, Heddy Landau, Alon Eliakim, Keith Lindley, Mark J. Dunne, Lydia Aguilar-Bryan and Benjamin Glaser

Endocrinology and Metabolism Service (S.T., J.L., M.H., Y.N., N.K., E.B.-S., O.S., E.N., T.P., B.G.), Internal Medicine Department, and Department of Pediatrics (D.Z., H.L.), Hadassah-Hebrew University Medical School, Jerusalem 91120, Israel; Departments of Medicine and Cellular and Molecular Biology (A.C., L.A.-B.), Baylor College of Medicine, Houston, Texas 77030; School of Biological Science (K.E.C., M.J.D.), The University of Manchester, Manchester M13 9PT, United Kingdom; The London Centre for Childhood Pancreatic Disease (K.H., K.L.), Great Ormond Street Hospital for Children National Health Service Trust, London WC1N 3JH, United Kingdom; The Institute of Child Health (K.H., K.L.), London WC1N 3JH, United Kingdom; Pediatric Endocrine Unit (Y.T.-R.), Ha’ Emek Medical Center, Afula 18101, Israel; Institute for Endocrinology and Diabetes (L.D.V.), National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva 49202 and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel; Hospital Infantil Universitario Niño Jesús (J.A.), E-28009 Madrid, Spain; Hospital Infantil Universitario La Paz (R.G.), E-28034 Madrid, Spain; and Pediatric Endocrinology Clinic (A.E.), Pediatric Department, Meir General Hospital, Kfar-Saba, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

Address all correspondence and requests for reprints to: Benjamin Glaser, M.D., Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. E-mail: beng{at}cc.huji.ac.il.

Hyperinsulinism of infancy is a genetically heterogeneous disease characterized by dysregulation of insulin secretion resulting in severe hypoglycemia. To date, mutations in five different genes, the sulfonylurea receptor (SUR1, ABCC8), the inward rectifying potassium channel (KIR6.2, KCNJ11), glucokinase (GCK), glutamate dehydrogenase (GLUD1), and short-chain 3-hydroxyacyl-coenzyme A dehydrogenase (SCHAD), have been implicated. Previous reports suggest that, in 40% of patients, no mutation can be identified in any of these genes, suggesting additional locus heterogeneity. However, previous studies did not screen all five genes using direct sequencing, the most sensitive technique available for mutation detection. We selected 15 hyperinsulinism of infancy patients and systematically sequenced the promoter and all coding exons and intron/exon boundaries of ABCC8 and KCNJ11. If no mutation was identified, the coding sequence and intron/exon boundaries of GCK, GLUD1, and SCHAD were sequenced. Seven novel mutations were found in the ABCC8 coding region, one mutation was found in the KCNJ11 coding region, and one novel mutation was found in each of the two promoter regions screened. Functional studies on ß-cells from six patients showed abnormal ATP-sensitive K+ channel function in five of the patients; the sixth had normal channel activity, and no mutations were found. Photolabeling studies using a reconstituted system showed that all missense mutations altered intracellular trafficking. Each of the promoter mutations decreased expression of a reporter gene by about 60% in a heterologous expression system. In four patients (27%), no mutations were identified. Thus, further genetic heterogeneity is suggested in this disorder. These patients represent a cohort that can be used for searching for mutations in other candidate genes.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
C James, R R Kapoor, D Ismail, and K Hussain
The genetic basis of congenital hyperinsulinism
J. Med. Genet., May 1, 2009; 46(5): 289 - 299.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. B T Christesen, N. D Tribble, A. Molven, J. Siddiqui, T. Sandal, K. Brusgaard, S. Ellard, P. R Njolstad, J. Alm, B. Brock Jacobsen, et al.
Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
Eur. J. Endocrinol., July 1, 2008; 159(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Abdulhadi-Atwan, J. D. Bushman, S. Tornovsky-Babaey, A. Perry, A. Abu-Libdeh, B. Glaser, S.-L. Shyng, and D. H. Zangen
Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence
Diabetes, July 1, 2008; 57(7): 1935 - 1940.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Hussain, S. E. Flanagan, V. V. Smith, M. Ashworth, M. Day, A. Pierro, and S. Ellard
An ABCC8 Gene Mutation and Mosaic Uniparental Isodisomy Resulting in Atypical Diffuse Congenital Hyperinsulinism
Diabetes, January 1, 2008; 57(1): 259 - 263.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F.-F. Yan, Y.-W. Lin, C. MacMullen, A. Ganguly, C. A. Stanley, and S.-L. Shyng
Congenital Hyperinsulinism Associated ABCC8 Mutations That Cause Defective Trafficking of ATP-Sensitive K+ Channels: Identification and Rescue
Diabetes, September 1, 2007; 56(9): 2339 - 2348.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F.-F. Yan, C.-W. Lin, E. A. Cartier, and S.-L. Shyng
Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1351 - C1359.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Marthinet, A. Bloc, Y. Oka, Y. Tanizawa, B. Wehrle-Haller, V. Bancila, J.-M. Dubuis, J. Philippe, and V. M. Schwitzgebel
Severe Congenital Hyperinsulinism Caused by a Mutation in the Kir6.2 Subunit of the Adenosine Triphosphate-Sensitive Potassium Channel Impairing Trafficking and Function
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5401 - 5406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society